Research News for May 27, 2020
advertisement
- Slowed Metabolic Decline After One Year of Oral Insulin Treatment Among Individuals at High Risk for Type 1 Diabetes in the Diabetes Prevention Trial-Type 1 and TrialNet Oral Insulin Prevention Trials (HTML)
- New research identifies two drug classes that could be re-purposed for type 1 diabetes treatment
- An integrated multi-omics approach identifies the landscape of interferon-α-mediated responses of human pancreatic beta cells
- Ultra Rapid Lispro Lowers Postprandial Glucose and More Closely Matches Normal Physiological Glucose Response Compared to Other Rapid Insulin Analogs: A Phase 1 Randomized, Crossover Study (HTML)
- Improving Blood Glucose Level Predictability Using Machine Learning (HTML)
- Trabecular Bone Score and Transilial Bone Trabecular Histomorphometry in Type 1 Diabetes and Healthy Controls (HTML)
- Determination of Carnitine Ester Profile in the Children With Type 1 Diabetes: A Valuable Step Towards a Better Management (HTML)
- Resistant Hypertension and Risk of Adverse Events in Individuals With Type 1 Diabetes: A Nationwide Prospective Study (HTML)
- Investigation of the Effect of Epicardial Adipose Tissue Thickness on Cardiac Conduction System in Children With Type 1 Diabetes Mellitus (HTML)
- A New Potential Mode of Cardiorenal Protection of KLOTHO Gene Variability in Type 1 Diabetic Adolescents (HTML)
- Failed Genetic Protection: Type 1 Diabetes in the Presence of HLA-DQB1*06:02 (HTML)
- Allograft Inflammatory factor-1 in Myeloid Cells Drives Autoimmunity in Type 1 Diabetes (HTML)
- Use of Culture to Reach Metabolically Adequate Beta Cell Dose by Combining Donor Islet Cell Isolates for Transplantation in Type 1 Diabetes Patients (HTML)
- Estimated Peak Systolic Pulmonary Artery Pressure in Young Non-Complicated Patients With Type 1 Diabetes (HTML)
